These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9952314

  • 1. The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.
    Stawowy P, Bonnet R, Rommelspacher H.
    Biochem Pharmacol; 1999 Mar 01; 57(5):511-20. PubMed ID: 9952314
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T, Greube A, Strauss S, Heineke D, Lehmann J, Rommelspacher H.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar 01; 349(3):308-17. PubMed ID: 8208308
    [Abstract] [Full Text] [Related]

  • 3. Oxidative metabolism of the bioactive and naturally occurring beta-carboline alkaloids, norharman and harman, by human cytochrome P450 enzymes.
    Herraiz T, Guillén H, Arán VJ.
    Chem Res Toxicol; 2008 Nov 01; 21(11):2172-80. PubMed ID: 19238614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 8. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
    Testai E, De Curtis V, Gemma S, Fabrizi L, Gervasi P, Vittozzi L.
    J Biochem Toxicol; 1996 Aug 22; 11(6):305-12. PubMed ID: 9176742
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
    Pawlik M, Rommelspacher H.
    Eur J Pharmacol; 1988 Mar 01; 147(2):163-71. PubMed ID: 3366173
    [Abstract] [Full Text] [Related]

  • 10. Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol.
    McGehee RE, Ronis MJ, Cowherd RM, Ingelman-Sundberg M, Badger TM.
    Biochem Pharmacol; 1994 Nov 01; 48(9):1823-33. PubMed ID: 7980652
    [Abstract] [Full Text] [Related]

  • 11. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
    Seaton MJ, Follansbee MH, Bond JA.
    Carcinogenesis; 1995 Oct 01; 16(10):2287-93. PubMed ID: 7586124
    [Abstract] [Full Text] [Related]

  • 12. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1).
    Albano E, Comoglio A, Clot P, Iannone A, Tomasi A, Ingelman-Sundberg M.
    Biochim Biophys Acta; 1995 Apr 13; 1243(3):414-20. PubMed ID: 7727516
    [Abstract] [Full Text] [Related]

  • 13. Norharman (beta-carboline) as a potent inhibitory ligand for steroidogenic cytochromes P450 (CYP11 and CYP17).
    Kühn-Velten WN.
    Eur J Pharmacol; 1993 Nov 30; 250(1):R1-3. PubMed ID: 8119304
    [Abstract] [Full Text] [Related]

  • 14. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
    Zhukov A, Ingelman-Sundberg M.
    Biochem J; 1999 Jun 01; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
    [Abstract] [Full Text] [Related]

  • 15. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
    Rommelspacher H, May T, Salewski B.
    Eur J Pharmacol; 1994 Jan 24; 252(1):51-9. PubMed ID: 8149995
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I, Wakazono H, Bergin P, de Waziers I, Beaune P, Kenna JG, Caldwell J.
    Carcinogenesis; 1997 Sep 24; 18(9):1775-83. PubMed ID: 9328175
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat.
    Badger TM, Ronis MJ, Lumpkin CK, Valentine CR, Shahare M, Irby D, Huang J, Mercado C, Thomas P, Ingelman-Sundberg M.
    J Pharmacol Exp Ther; 1993 Jan 24; 264(1):438-47. PubMed ID: 8423543
    [Abstract] [Full Text] [Related]

  • 18. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
    Crosbie SJ, Blain PG, Williams FM.
    Hum Exp Toxicol; 1997 Mar 24; 16(3):131-7. PubMed ID: 9088965
    [Abstract] [Full Text] [Related]

  • 19. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
    Valoti M, Fusi F, Frosini M, Pessina F, Tipton KF, Sgaragli GP.
    Eur J Pharmacol; 2000 Mar 17; 391(3):199-206. PubMed ID: 10729359
    [Abstract] [Full Text] [Related]

  • 20. Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
    Pawlik M, Kaulen P, Baumgarten HG, Rommelspacher H.
    J Chem Neuroanat; 1990 Mar 17; 3(1):19-24. PubMed ID: 2156525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.